Immunotherapy & Targeted Therapy Advances

This track covers breakthroughs in immunotherapy and targeted cancer treatments. It highlights immune checkpoint inhibitors, CAR-T cell therapy, and monoclonal antibodies. Discussions include mechanisms of immune response and resistance. The session explores combination therapies for enhanced effectiveness. Advances in targeted drug delivery will also be discussed. Clinical outcomes and ongoing research will be reviewed. Participants will learn about next-generation therapies. Overall, this track focuses on innovative approaches to cancer treatment.

 

    Related Conference of Immunotherapy & Targeted Therapy Advances

    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 03-04, 2026

    10th Global Meeting on Oncology and Radiology

    Madrid, Spain
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France
    February 15-16, 2027

    5th World Congress on Oral Cancer

    Singapore City, Singapore
    April 15-16, 2027

    12th World Conference on Breast and Cervical Cancer

    Amsterdam, Netherlands

    Immunotherapy & Targeted Therapy Advances Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in